Pat Killingsworth Pat Killingsworth

Stranger than fiction? Cialis an anti-myeloma drug?

I ended yesterday’s post with a flip blip about how Cialis features a precautionary warning specifically naming mutliple myeloma.  Ironic, since our good friend, Holt, followed-up with an even stranger Cialis-related email.  Turns-out that Cialis (tadalafil) is being tested in ongoing human studies as an anti-multiple meyloma drug!  You can’t make this stuff up!

According to ClinicalTrials.gov:

The primary objective of this study is to evaluate the anti-tumor efficacy of tadalafil in combination with Lenalidomide/dexamethasone (Rd) in multiple myeloma.

This is a Phase 2 study, so someone out there must think it has a chance–these studies are very expensive to recruit for and administer.  Making all of this even stranger, the host institution will be Sidney Kimmel Comprehensive Cancer Center.  Ring a bell?  That’s Johns Hopkins cancer center in questions from Tuesday, part of the cancer nutrition post/hoax we brought to light the past two days.

Truth can be stranger than fiction.  Like I said, you can’t make this stuff up!

Here’s a link to the Revlimid/Cialis/dex study that’s recruiting now:

http://clinicaltrials.gov/show/NCT01374217

Get out there and sign-up, guys!  Talk about a big-time win/win!  Fight your myeloma and get free erectile dysfunction meds at the same time!  Those things are expensive–not that I would know…

cialisAnd this would be a big win for the company that manufactures Cialis, Lilly.  Even if this “out there” drug combo only helps a little, off-label use would allow doctors to prescribe it even if the combination’s efficacy fell below FDA standards.

So why not throw a few erectile dysfunction drugs at the wall and see if any stick?  These companies can afford it!  Another reason I find it ironic that muliple myeloma would be specifically singled-out on Lilly’s cautionary Cialis label.

Strange stuff!  Feel good and keep smiling!  Pat